May 17, 2011

      THE CHRONICLE OF HIGHER EDUCATION Academic Freedom and the Corporate University March 3, 2011

Read More
Academic Freedom & the Corporate University

February 16, 2009

  The government and judiciary are largely to blame for keeping vital drug safety information concealed from

Read More
AstraZeneca Wants to Conceal Seroquel Information

February 25, 2007

Evelyn Pringle reports (below) that the group is also supporting Jim Gottstein in his battle with Eli

Read More
Activists Take on Eli Lilly Over Off-Label Marketing & Harm Caused by Zyprexa

February 13, 2007

The documents contain evidence of Lilly’s marketing strategy promoting Zyprexa for unapproved, off-label uses while concealing from doctors

Read More
Court Ruling: Injunction on Release of Zyprexa Documents

February 13, 2007

A federal Judge of the Eastern District (Brooklyn) issued a ruling upholding a seal on documents that

Read More
Zyprexa Documents Court Ruling

February 6, 2007

Eli Lilly's executives have driven the company to a point of no return. The company is being

Read More
SEC Filings: Eli Lilly Admits Problems Getting Liability Insurance For Zyprexa

January 22, 2007

Below are excerpts from two timely articles that offer persuasive arguments backed by evidence demonstrating that litigation

Read More
Role of Litigation in Defining Drug Risks_JAMA / BMJ

December 20, 2006

The New York Times reports (below) that a federal court overseeing Zyprexa litigation has ordered Jim Gottstein

Read More
Eli Lilly Lies About Zyprexa_NYT Editorial Calls for CongressionalHearings

December 17, 2006

The legal battle over Eli Lilly's Zyprexa documents–which were released to The New York Times in December,2006–was

Read More
Two Days in in U.S. Federal District Court Re: Lilly Zyprexa Documents

January 10, 2002

An  article in In These Times provides an overview of recent ethical violations in US medical experiments

Read More
The Prison as Laboratory_2002